2,110
Views
100
CrossRef citations to date
0
Altmetric
Research Article

Survival and prognostic factors in chondrosarcoma

Results in 115 patients with long-term follow-up

, , , , &
Pages 749-755 | Received 21 Feb 2010, Accepted 04 Aug 2011, Published online: 09 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Minna K. Laitinen, Jose I. Albergo, Jonathan D. Stevenson, German L. Farfalli, Luis A. Aponte-Tinao, Robert J. Grimer, Lee M. Jeys & Michael C. Parry. (2020) Female gender in the hormonally active age group plays a major role in high-grade chondrosarcoma survival. Acta Oncologica 59:2, pages 242-246.
Read now
Joachim Thorkildsen, Ingeborg Taksdal, Bodil Bjerkehagen, Hans Kristian Haugland, Tom Børge Johannesen, Trond Viset, Ole-Jacob Norum, Øyvind Bruland & Olga Zaikova. (2019) Chondrosarcoma in Norway 1990–2013; an epidemiological and prognostic observational study of a complete national cohort. Acta Oncologica 58:3, pages 273-282.
Read now
Tomoki Nakamura, Akihiko Matsumine, Satoshi Yamada, Satoshi Tsukushi, Katsuhisa Kawanami, Takatoshi Ohno, Hirohisa Katagiri, Hideshi Sugiura, Kenji Yamada, Yoshihisa Yamada, Akihiro Sudo & Yoshihiro Nishida. (2016) Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study. OncoTargets and Therapy 9, pages 4747-4751.
Read now

Articles from other publishers (97)

Liming Jiang, Yan Gong, Jiajia Jiang & Dongxu Zhao. (2023) Construction of novel predictive tools for post-surgical cancer-specific survival probability in patients with primary chondrosarcoma and external validation in Chinese cohorts: a large population-based retrospective study. Journal of Cancer Research and Clinical Oncology 149:14, pages 13027-13042.
Crossref
Liming Jiang, Yan Gong, Jiajia Jiang & Dongxu Zhao. (2023) The novel dynamic nomogram and risk classification system constructed for predicting post-surgical overall survival and mortality risk in primary chondrosarcoma: a population study based on SEER database. Journal of Cancer Research and Clinical Oncology 149:14, pages 12765-12778.
Crossref
Minna K. Laitinen, Gilber Kask, Katariina Laurila, Erkki J. Tukiainen, Mikko Rönty, Ville Haapamäki & Juho T.K. Salo. (2023) Chondrosarcoma of the Chest Wall. Annals of Plastic Surgery 90:2, pages 151-155.
Crossref
Charles E. Mackel, Harry Rosenberg, Hemant Varma, Erik J. Uhlmann, Rafael A. Vega & Ron L. Alterman. (2023) Intracranial Metastasis of Extracranial Chondrosarcoma: Systematic Review With Illustrative Case. Brain Tumor Research and Treatment 11:2, pages 103.
Crossref
Alberto Righi, Marina Pacheco, Stefania Cocchi, Sofia Asioli, Marco Gambarotti, Davide Maria Donati, Andrea Evangelista, Maria Gnoli, Manuela Locatelli, Marina Mordenti, Manila Boarini, Evelise Brizola, Elena Pedrini & Luca Sangiorgi. (2022) Secondary peripheral chondrosarcoma arising in solitary osteochondroma: variables influencing prognosis and survival. Orphanet Journal of Rare Diseases 17:1.
Crossref
Makoto Nakagawa, Masaya Sekimizu, Makoto Endo, Eisuke Kobayashi, Shintaro Iwata, Suguru Fukushima, Akihiko Yoshida, Issay Kitabayashi, Hitoshi Ichikawa, Akira Kawai & Fumihiko Nakatani. (2022) Prognostic impact of IDH mutations in chondrosarcoma. Journal of Orthopaedic Science 27:6, pages 1315-1322.
Crossref
Meng Dong, Ruifeng Liu, Qiuning Zhang, Hongtao Luo, Dandan Wang, Yuhang Wang, Junru Chen, Yuhong Ou & Xiaohu Wang. (2022) Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis. Radiation Oncology 17:1.
Crossref
Kok-Lun Pang, Lian-Chee Foong, Norzana Abd Ghafar, Ima Nirwana Soelaiman, Jia Xian Law, Lek Mun Leong & Kok-Yong Chin. (2022) Transcriptomic Analysis of the Anticancer Effects of Annatto Tocotrienol, Delta-Tocotrienol and Gamma-Tocotrienol on Chondrosarcoma Cells. Nutrients 14:20, pages 4277.
Crossref
Li-Bo Zhou, He-Cheng Zhang, Zai-Gang Dong & Chao-Chao Wang. (2022) Chondrosarcoma of the toe: A case report and literature review. World Journal of Clinical Cases 10:25, pages 9132-9141.
Crossref
Taylor D. Ottesen, Blake N. Shultz, Alana M. Munger, Michael Amick, Courtney S. Toombs, Gary E. Friedaender & Jonathan N. Grauer. (2022) Chondrosarcoma patient characteristics, management, and outcomes based on over 5,000 cases from the National Cancer Database (NCDB). PLOS ONE 17:7, pages e0268215.
Crossref
Wenle Li, Gui Wang, Rilige Wu, Shengtao Dong, Haosheng Wang, Chan Xu, Bing Wang, Wanying Li, Zhaohui Hu, Qi Chen & Chengliang Yin. (2022) Dynamic Predictive Models With Visualized Machine Learning for Assessing Chondrosarcoma Overall Survival. Frontiers in Oncology 12.
Crossref
Eiji Kozawa, Yoshihiro Nishida, Akira Kawai, Keiko Hayakawa, Nokitaka Setsu, Hiroyuki Kawashima, Shintaro Iwata, Hiroyuki Tsuchiya, Satoshi Tsukushi, Satoshi Takenaka, Jungo Imanishi, Ichiro Baba, Akihito Nagano, Takeshi Morii, Toshiharu Shirai, Koki Shimizu & Hirotaka Kawano. (2022) Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi‐institutional study. Cancer Science 113:7, pages 2397-2408.
Crossref
Yuexin Tong, Yuekai Cui, Liming Jiang, Yangwei Pi, Yan Gong & Dongxu Zhao. (2022) Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study. Frontiers in Public Health 10.
Crossref
Lee D. Cranmer, Bonny Chau, Jose G. Mantilla, Elizabeth T. Loggers, Seth M. Pollack, Teresa S. Kim, Edward Y. Kim, Gabrielle M. Kane, Matthew J. Thompson, Jared L. Harwood & Michael J. Wagner. (2022) Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis. Clinical Orthopaedics & Related Research 480:4, pages 748-758.
Crossref
Zheng-Wei Xiao, Hui-ling Guo, Hong-chao Chen, Lai-peng Yan, Yi-lin Liao, Shu-lin Li, Li-lan Zhao, Ling-bo Su, Jun-jie Li & Fa-qiang Tang. (2022) Prevalence, Risk Factors, and Prognostic Factors of Primary Malignant Bone Neoplasms with Bone Metastasis at Initial Diagnosis: A Population-Based Study. Journal of Oncology 2022, pages 1-14.
Crossref
Daniel R. Evans, Alexander L. Lazarides, Mark M. Cullen, Jason A. Somarelli, Dan G. BlazerIIIIII, Julia D. Visguass, Brian E. Brigman & William C. Eward. (2021) Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study. Annals of Surgical Oncology 29:2, pages 1392-1408.
Crossref
Miao Wang, Yu Song, Shengfu Liu & Weibing Sun. (2022) Effect of surgery and radiotherapy on overall survival in patients with chondrosarcoma: A SEER-based study. Journal of Orthopaedic Surgery 30:1, pages 102255362210863.
Crossref
Mariana Camacho, Marcela Carvalho, Rodrigo Munhoz, Mauricio Etchebehere & Elba Etchebehere. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging 445 465 .
Björn Vogt, Georg Gosheger & Dimosthenis Andreou. 2020. Orthopädie und Unfallchirurgie. Orthopädie und Unfallchirurgie 1 23 .
Rafael Martinez-Perez & A. Samy Youssef. 2022. Contemporary Skull Base Surgery. Contemporary Skull Base Surgery 717 727 .
Wenle Li, Shengtao Dong, Haosheng Wang, Rilige Wu, Huitao Wu, Zhi-Ri Tang, Junyan Zhang, Zhaohui Hu & Chengliang Yin. (2021) Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database. BMC Musculoskeletal Disorders 22:1.
Crossref
Abdulaziz Alqubaisi, Ines Oliveira, Nehal Singla, Anesh Chavda, Michael Khoo & Asif Saifuddin. (2020) The incidence and diagnostic relevance of pathological fracture in conventional central chondrosarcoma. Skeletal Radiology 50:6, pages 1131-1140.
Crossref
Agnieszka E. Zając, Sylwia Kopeć, Bartłomiej Szostakowski, Mateusz J. Spałek, Michał Fiedorowicz, Elżbieta Bylina, Paulina Filipowicz, Anna Szumera-Ciećkiewicz, Andrzej Tysarowski, Anna M. Czarnecka & Piotr Rutkowski. (2021) Chondrosarcoma-from Molecular Pathology to Novel Therapies. Cancers 13:10, pages 2390.
Crossref
Matthew E. Wells, Michael D. Eckhoff, Lisa A. Kafchinski, Elizabeth M. Polfer & Benjamin K. Potter. (2021) Conventional Cartilaginous Tumors. JBJS Reviews 9:5.
Crossref
Sjoerd P. F. T. Nota, Ahmad Al-Sukaini, Shalin S. Patel, Francesco Sabbatino, G. Petur Nielsen, Vikram Deshpande, Jennifer H. Yearley, Soldano Ferrone, Xinhui Wang & Joseph H. Schwab. (2021) High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease. Frontiers in Oncology 11.
Crossref
Tomohiro Fujiwara, Yoichi Kaneuchi, Jonathan Stevenson, Michael Parry, Vineet Kurisunkal, Rhys Clark, Yusuke Tsuda, Minna Laitinen, Robert Grimer & Lee Jeys. (2021) Navigation-assisted pelvic resections and reconstructions for periacetabular chondrosarcomas. European Journal of Surgical Oncology 47:2, pages 416-423.
Crossref
Joachim Thorkildsen, Ole‐Jacob Norum, Tor A. Myklebust & Olga Zaikova. (2020) Chondrosarcoma local recurrence in the Cancer Registry of Norway cohort (1990–2013): Patterns and impact. Journal of Surgical Oncology 123:2, pages 510-520.
Crossref
Yat Hang To, Lisa Orme & Jeremy Lewin. 2021. Sarcoma. Sarcoma 189 212 .
Kehan Song, Kaiyuan Lin, Honglei Kang, Yiming Dong, Hanfeng Guan & Feng Li. (2020) Primary Tumor Resection Prolongs Survival in Spinal Chondrosarcoma Patients With Distant Metastasis. Spine 45:24, pages E1661-E1668.
Crossref
Yusuke Tsuda, Kim Tsoi, Jonathan D. Stevenson, Minna Laitinen, Peter C. Ferguson, Jay S. Wunder, Anthony M. Griffin, Michiel A. J. van de Sande, Veroniek van Praag, Andreas Leithner, Tomohiro Fujiwara, Hideo Yasunaga, Hiroki Matsui, Michael C. Parry & Lee M. Jeys. (2020) Development and external validation of nomograms to predict sarcoma-specific death and disease progression after surgical resection of localized high-grade conventional primary central chondrosarcoma and dedifferentiated chondrosarcoma. The Bone & Joint Journal 102-B:12, pages 1752-1759.
Crossref
Ira Goldsmith, Peter Llewelyn Evans, Heather Goodrum, James Warbrick-Smith & Thomas Bragg. (2020) Chest wall reconstruction with an anatomically designed 3-D printed titanium ribs and hemi-sternum implant. 3D Printing in Medicine 6:1.
Crossref
Changseok Lee, David Forner, Martin Bullock, Matthew H. Rigby, Martin Corsten, Jonathan R. Trites & S. Mark Taylor. (2020) Open resection and reconstruction of a Nasoseptal Chondrosarcoma: case report and literature review. Journal of Otolaryngology - Head & Neck Surgery 49:1.
Crossref
Lin Xie, Weibo Huang, Hongli Wang, Chaojun Zheng & Jianyuan Jiang. (2020) Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study. Journal of Orthopaedic Surgery and Research 15:1.
Crossref
Ana Belén Carrillo-Gálvez, Juan Esteban Quintero, René Rodríguez, Sofía T. Menéndez, M. Victoria González, Verónica Blanco-Lorenzo, Eva Allonca, Virgínea de Araújo Farias, Juan Elías González-Correa, Nadina Erill-Sagalés, Iñigo Martínez-Zubiaurre, Turid Hellevik, Sabina Sánchez-Hernández, Pilar Muñoz, Federico Zurita, Francisco Martín, Juan Carlos Rodríguez-Manzaneque & Per Anderson. (2020) GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β. Cell Death & Disease 11:11.
Crossref
Caroline Granger, Aaron Hoyt, Alexandra Moran, Beatrice Becker, Anil� Sedani, Shannon Saigh, Sheila Conway, Jeffrey Brown & Karina Galoian. (2020) Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1. Molecular Medicine Reports.
Crossref
Ajay Puri, Ashish Gulia, Vineet John Kurisunkal, Vivek Sukumar & Bharat Rekhi. (2019) Chondrosarcomas in adolescents: are they different?. Journal of Pediatric Orthopaedics B 29:5, pages 505-509.
Crossref
Lee D. Cranmer, Bonny Chau, Matthew J. Thompson, Elizabeth T. Loggers, Seth M. Pollack, Michael J. Wagner, Teresa S. Kim, Edward Y. Kim, Gabrielle M. Kane & Gabriel J. Pavey. (2020) Impact of nodal involvement on survival outcomes in chondrosarcoma: retrospective cohort analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004–2015). International Journal of Surgery Oncology 5:4.
Crossref
Yi-Chou Chen, Po-Kuei Wu, Chao-Ming Chen, Shang-Wen Tsai, Cheng-Fong Chen & Wei-Ming Chen. (2020) Prognostic factors and survival in conventional chondrosarcoma: A single institution review. Journal of the Chinese Medical Association 83:7, pages 669-673.
Crossref
Joachim Thorkildsen, Ingeborg Taksdal, Bodil Bjerkehagen, Ole‐Jacob Norum, Tor Age Myklebust & Olga Zaikova. (2020) Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort. Journal of Surgical Oncology 121:7, pages 1115-1125.
Crossref
E. McLoughlin, A.M. Davies, A. Iqbal, S.L. James & R. Botchu. (2020) The diagnostic significance of pulmonary nodules on CT thorax in chondrosarcoma of bone. Clinical Radiology 75:5, pages 395.e7-395.e16.
Crossref
Mario D’Acunto, Raffaele Gaeta, Rodolfo Capanna & Alessandro Franchi. (2020) Contribution of Raman Spectroscopy to Diagnosis and Grading of Chondrogenic Tumors. Scientific Reports 10:1.
Crossref
Andrew S. Venteicher, Michael M. McDowell, Ezequiel Goldschmidt, Eric W. Wang, Carl H. Snyderman & Paul A. Gardner. (2020) A preoperative risk classifier that predicts tumor progression in patients with cranial base chondrosarcomas. Journal of Neurosurgery, pages 1-9.
Crossref
Margaret L. Compton & Justin M.M. Cates. (2020) Evidence-based Tumor Staging of Skeletal Chondrosarcoma. American Journal of Surgical Pathology 44:1, pages 111-119.
Crossref
Sergio Piña-Oviedo, Jae Y. Ro & Alberto G. Ayala. 2020. Tumors and Tumor-Like Lesions of Bone. Tumors and Tumor-Like Lesions of Bone 317 351 .
Julian Fromm, Alexander Klein, Andrea Baur-Melnyk, Thomas Knösel, Lars Lindner, Christof Birkenmaier, Falk Roeder, Volkmar Jansson & Hans Roland Dürr. (2019) Survival and prognostic factors in conventional G1 chondrosarcoma. World Journal of Surgical Oncology 17:1.
Crossref
Georg W. Omlor, Vera Lohnherr, Jessica Lange, Simone Gantz, Gunhild Mechtersheimer, Christian Merle, Patric Raiss, Joerg Fellenberg & Burkhard Lehner. (2019) Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients. BMC Musculoskeletal Disorders 20:1.
Crossref
Lile He, Xiangyu Shi, Ruiqi Chen, Zhengchun Wu, Zhulin Yang & Zhihong Li. (2019) Association of Mental Health-Related Proteins DAXX, DRD3, and DISC1 With the Progression and Prognosis of Chondrosarcoma. Frontiers in Molecular Biosciences 6.
Crossref
Michiel E. R. Bongers, Quirina C. B. S. Thio, Aditya V. Karhade, Merel L. Stor, Kevin A. Raskin, Santiago A. Lozano Calderon, Thomas F. DeLaney, Marco L. Ferrone & Joseph H. Schwab. (2019) Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation. Clinical Orthopaedics & Related Research 477:10, pages 2296-2303.
Crossref
Makoto Nakagawa, Fumihiko Nakatani, Hironori Matsunaga, Takahiko Seki, Makoto Endo, Yoko Ogawara, Yukino Machida, Takuo Katsumoto, Kazutsune Yamagata, Ayuna Hattori, Shuhei Fujita, Yukiko Aikawa, Takamasa Ishikawa, Tomoyoshi Soga, Akira Kawai, Hirokazu Chuman, Nobuhiko Yokoyama, Suguru Fukushima, Kenichiro Yahiro, Atsushi Kimura, Eijiro Shimada, Takeshi Hirose, Toshifumi Fujiwara, Nokitaka Setsu, Yoshihiro Matsumoto, Yukihide Iwamoto, Yasuharu Nakashima & Issay Kitabayashi. (2019) Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma. Oncogene 38:42, pages 6835-6849.
Crossref
Hongliang Gao, Yuanxi Zhou, Zhan Wang, Renbo Zhao & Shengjun Qian. (2019) Clinical features and prognostic analysis of patients with chest wall chondrosarcoma. Medicine 98:36, pages e17025.
Crossref
Li Chen, Cheng Long, Jiaxin Liu, Xin Duan & Zhou Xiang. (2019) Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma. Cancer Medicine 8:12, pages 5438-5449.
Crossref
Edwin F Dierselhuis, Krista A Goulding, Martin Stevens & Paul C Jutte. (2019) Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones. Cochrane Database of Systematic Reviews 2019:4.
Crossref
M. K. LaitinenM. C. ParryL-R. Le NailC. H. WigleyJ. D. StevensonL. M. Jeys. (2019) Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision. The Bone & Joint Journal 101-B:3, pages 266-271.
Crossref
Kehan Song, Jian Song, Feiyan Chen, Kaiyuan Lin, Xiaosheng Ma & Jianyuan Jiang. (2019) Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?. Clinical Orthopaedics & Related Research 477:3, pages 573-583.
Crossref
Michael J Cruz Caliz, Modesto González-Del Rosario, Iván González-Cancel, Ricardo Fernández González, John Pagán, Christian Castillo Latorre, Juan M García Puebla & Aixa Dones Rodríguez. (2019) Resection and primary reconstruction of a massive chest wall chondrosarcoma. Oxford Medical Case Reports 2019:2.
Crossref
Nesrine Tounsi, Ines Zemni, Nawel Abdelwahed, Ichraf Jbir, Lamia Charfi, Radhi Ben Nasser, Riadhe Chargui & Khaled Rahel. (2019) Costal chondrosarcoma mimicking a breast cancer: Case report and review of literature. International Journal of Surgery Case Reports 56, pages 37-39.
Crossref
Frank M. Klenke, Attila Kollár & Christophe Kurze. 2019. Fractures of the Hip. Fractures of the Hip 155 167 .
Julian Fromm, Alexander Klein, Andrea Baur-Melnyk, Thomas Knösel, Lars Lindner, Christof Birkenmaier, Falk Roeder, Volkmar Jansson & Hans Roland Dürr. (2018) Survival and prognostic factors in conventional central chondrosarcoma. BMC Cancer 18:1.
Crossref
Kehan Song, Xiao Shi, Xin Liang, Hongli Wang, Fei Zou, Feizhou Lu, Xiaosheng Ma & Jianyuan Jiang. (2018) Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study. International Orthopaedics 42:12, pages 2941-2948.
Crossref
Jui‐Chieh Chen, Cheng Huang, I‐Neng Lee, Yu‐Ping Wu & Chih‐Hsin Tang. (2018) Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway. Molecular Carcinogenesis 57:12, pages 1816-1824.
Crossref
Georg W. Omlor, Vera Lohnherr, Pit Hetto, Simone Gantz, Jörg Fellenberg, Christian Merle, Thorsten Guehring & Burkhard Lehner. (2018) Surgical therapy of benign and low-grade malignant intramedullary chondroid lesions of the distal femur: intralesional resection and bone cement filling with or without osteosynthesis. Strategies in Trauma and Limb Reconstruction 13:3, pages 163-170.
Crossref
Kehan Song, Jian Song, Xio Shi, Hongli Wang, Xiaosheng Ma, Xinlei Xia, Xin Liang, Kaiyuan Lin & Jianyuan Jiang. (2018) Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients. Spine 43:21, pages E1281-E1289.
Crossref
Quirina C. B. S. Thio, Aditya V. Karhade, Paul T. Ogink, Kevin A. Raskin, Karen De Amorim Bernstein, Santiago A. Lozano Calderon & Joseph H. Schwab. (2018) Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?. Clinical Orthopaedics & Related Research 476:10, pages 2040-2048.
Crossref
V.M. van Praag (Veroniek), A.J. Rueten-Budde, V. Ho, P.D.S. Dijkstra, M. Fiocco, M.A.J. van de Sande, Ingrid C. van der Geest, Jos A. Bramer, Gerard R. Schaap, Paul C. Jutte, HW Bart Schreuder & J.J.W. Ploegmakers. (2018) Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas. Surgical Oncology 27:3, pages 402-408.
Crossref
Carmine Zoccali, Jacopo Baldi, Dario Attala, Barbara Rossi, Vincenzo Anelli, Alessio Annovazzi & Virginia Ferraresi. (2018) Intralesional vs. extralesional procedures for low-grade central chondrosarcoma: a systematic review of the literature. Archives of Orthopaedic and Trauma Surgery 138:7, pages 929-937.
Crossref
Mark J. Landau, Ido Badash, Christine Yin, Ram K. Alluri & Ketan M. Patel. (2018) Free vascularized fibula grafting in the operative treatment of malignant bone tumors of the upper extremity: A systematic review of outcomes and complications. Journal of Surgical Oncology 117:7, pages 1432-1439.
Crossref
J. G. Gerbers, E. F. Dierselhuis, M. Stevens, J. J. W. Ploegmakers, S. K. Bulstra & P. C. Jutte. (2018) Computer-assisted surgery compared to fluoroscopy in curettage of atypical cartilaginous tumors / chondrosarcoma grade 1 in the long bones. PLOS ONE 13:5, pages e0197033.
Crossref
M. K. LaitinenJ. D. StevensonM. C. ParryV. SumathiR. J. GrimerL. M. Jeys. (2018) The role of grade in local recurrence and the disease-specific survival in chondrosarcomas. The Bone & Joint Journal 100-B:5, pages 662-666.
Crossref
Kehan Song, Xiao Shi, Hongli Wang, Fei Zou, Feizhou Lu, Xiaosheng Ma, Xinlei Xia & Jianyuan Jiang. (2018) Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?. Clinical Orthopaedics & Related Research 476:5, pages 987-996.
Crossref
Michaël P.A. Bus, Domenico A. Campanacci, Jose I. Albergo, Andreas Leithner, Michiel A.J. van de Sande, Czar Louie Gaston, Giuseppe Caff, Jan Mettelsiefen, Rodolfo Capanna, Per-Ulf Tunn, Lee M. Jeys & P.D. Sander Dijkstra. (2018) Conventional Primary Central Chondrosarcoma of the Pelvis. Journal of Bone and Joint Surgery 100:4, pages 316-325.
Crossref
Shelvin Kumar Vadi, Bhagwant Rai Mittal, Arun Kumar Reddy Gorla, Ashwani Sood, Rajender Kumar Basher, Apurva Sood, Nandita Kakkar & Ramesh K. Sen. (2018) 18F-FDG PET/CT in Diagnostic and Prognostic Evaluation of Patients With Suspected Recurrence of Chondrosarcoma. Clinical Nuclear Medicine 43:2, pages 87-93.
Crossref
Jyoti Bajpai, Nehal Khanna, Tushar Vora, Ashish Gulia, Siddhartha Laskar, Ajay Puri, Bhanupriya Sanduptla, Girish Chinnaswamy, Prakash Nayak, ShashikantL Juvekar, Amit Janu, Subhash Desai, Jaya Ghosh, Nilendu Purandare, Mukta Ramadwar, Venkatesh Rangarajan & Bharat Rekhi. (2018) Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes. Indian Journal of Cancer 55:1, pages 37.
Crossref
Elizabeth J. Davis, Scott M. Schuetze & Rashmi Chugh. 2018. Chordomas and Chondrosarcomas of the Skull Base and Spine. Chordomas and Chondrosarcomas of the Skull Base and Spine 419 427 .
Julie K. Silver, Vishwa S. Raj & Eric M. Wisotzky. 2018. Quality Cancer Care. Quality Cancer Care 119 147 .
Timothy J. Evans, Nicholas B. Frisch, Gary Gibson, Michael P. Mott & Theodore W. ParsonsIIIIII. (2017) VALIDATION OF A RAT MODEL FOR ANALYZING MicroRNA IN CHONDROSARCOMA. Journal of Musculoskeletal Research 20:04, pages 1750021.
Crossref
Karina Galoian, Shihua Luo & Parthik Patel. (2017) Analysis of IL6‑protein complexes in chondrosarcoma. Biomedical Reports.
Crossref
C. StihsenJ. PanotopoulosS. E. PuchnerF. SeveldaA. KaiderR. WindhagerP. T. Funovics. (2017) The outcome of the surgical treatment of pelvic chondrosarcomas. The Bone & Joint Journal 99-B:5, pages 686-696.
Crossref
S. P. F. T. Nota, M. J. A. M. Russchen, K. A. Raskin, H. J. Mankin, F. J. Hornicek & J. H. Schwab. (2016) Functional and oncological outcome after surgical resection of the scapula and clavicle for primary chondrosarcoma. MUSCULOSKELETAL SURGERY 101:1, pages 67-73.
Crossref
Pablo D. Roitman, Germ?n L. Farfalli, Miguel A. Ayerza, D. Luis M?scolo, Federico E. Milano & Luis A. Aponte-Tinao. (2016) Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?. Clinical Orthopaedics and Related Research? 475:3, pages 808-814.
Crossref
A. Dubory, G. Missenard & C. Court. (2016) Tratamiento quir?rgico de los tumores malignos primarios de la columna vertebral y del sacro. EMC - T?cnicas Quir?rgicas - Ortopedia y Traumatolog?a 8:4, pages 1-13.
Crossref
Alyaa Al-Ibraheemi & Alexandra Kalof. (2016) Paraspinal mesenchymal tumors: the overlap between neuropathology and soft tissue pathology. Diagnostic Histopathology 22:11, pages 458-471.
Crossref
Bronek Boszczyk. (2016) Expert?s comment concerning Grand Rounds case entitled ?Cervical subtotal en-bloc spondylectomy of C6 mesenchymal chondrosarcoma? (Chang-Hwa Lee and Woo-Kie Min); Eur Spine J (2015): DOI 10.1007/s00586-015-4297-z. European Spine Journal 25:7, pages 2124-2128.
Crossref
Dimosthenis Andreou, Magdalena M. Gilg, Georg Gosheger, Mathias Werner, Jendrik Hardes, Daniel Pink, Andreas Leithner, Per-Ulf Tunn & Arne Streitbürger. (2015) Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study. Annals of Surgical Oncology 23:1, pages 120-125.
Crossref
Mathias Werner. 2016. Pathologie. Pathologie 1125 1218 .
Julia Crim, Robert Schmidt, Lester Layfield, Christopher Hanrahan & Betty Jean Manaster. (2015) Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma?. European Journal of Radiology 84:11, pages 2222-2230.
Crossref
Srimanth Bindiganavile, Ilkyu Han, Ji Yeon Yun & Han-Soo Kim. (2015) Long-term Outcome of Chondrosarcoma: A Single Institutional Experience. Cancer Research and Treatment 47:4, pages 897-903.
Crossref
Eiichi Konishi, Yasuaki Nakashima, Masayuki Mano, Yasuhiko Tomita, Ikumitsu Nagasaki, Toshikazu Kubo, Nobuhito Araki, Hironori Haga, Junya Toguchida, Takafumi Ueda, Toshiko Sakuma, Masaya Imahori, Eiichi Morii, Hideki Yoshikawa, Yoshitane Tsukamoto, Hiroyuki Futani, Kenichi Wakasa, Manabu Hoshi, Shinshichi Hamada, Hideyuki Takeshita, Takeshi Inoue, Masanari Aono, Kenji Kawabata, Hiroaki Murata, Kanade Katsura, Yoji Urata, Hideki Ueda & Akio Yanagisawa. (2015) Primary central chondrosarcoma of long bone, limb girdle and trunk: Analysis of 174 cases by numerical scoring on histology. Pathology International 65:9, pages 468-475.
Crossref
P.-U. Tunn & M. Werner. (2015) Osteosarkomatös dedifferenziertes ChondrosarkomOsteosarcomatous dedifferentiated chondrosarcoma. Der Orthopäde 44:9, pages 720-723.
Crossref
Robert B. MacIntosh, Faisal Khan & Bret M. Waligora. (2015) Chondrosarcoma of the Temporomandibular Disc: Behavior Over?a?28-Year Observation Period. Journal of Oral and Maxillofacial Surgery 73:3, pages 465-474.
Crossref
Chun-Hao Tsai, Hsiao-Chi Tsai, Ho-Ning Huang, Chih-Hung Hung, Chin-Jung Hsu, Yi-Chin Fong, Horng-Chaung Hsu, Yuan-Li Huang & Chih-Hsin Tang. (2014) Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells. Oncotarget 6:1, pages 258-270.
Crossref
Sjoerd P. F. T. Nota, Yvonne Braun, Joseph H. Schwab, C. Niek van Dijk & Jos A. M. Bramer. (2015) The Identification of Prognostic Factors and Survival Statistics of Conventional Central Chondrosarcoma. Sarcoma 2015, pages 1-11.
Crossref
Sergio Piña-Oviedo, Jae Y. Ro, Alberto G. Ayala & Yong-Koo Park. 2015. Tumors and Tumor-Like Lesions of Bone. Tumors and Tumor-Like Lesions of Bone 295 348 .
H.R. D?rr, Y. Bakhshai, H. Rechl & P.-U. Tunn. (2014) Tumorresektion: Wie weit ist weit genug?Resection margins in bone tumors: what is adequate?. Der Unfallchirurg 117:7, pages 593-599.
Crossref
P. Anract, F. Larousserie, O. Mir & A. Feydy. (2014) Condrosarcomas. EMC - Aparato Locomotor 47:1, pages 1-14.
Crossref
Domenico Andrea Campanacci, Guido Scoccianti, Alessandro Franchi, Giuliana Roselli, Giovanni Beltrami, Massimiliano Ippolito, Giuseppe Caff, Filippo Frenos & Rodolfo Capanna. (2013) Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton. Journal of Orthopaedics and Traumatology 14:2, pages 101-107.
Crossref
Seung Han Shin, Hyeon Jang Jeong, Ilkyu Han, Hwan Seong Cho & Han-Soo Kim. (2013) Osteosarcoma and Chondrosarcoma of the Shoulder: Site-specific Comparative Analysis. Orthopedics 36:2.
Crossref
. (2012) Oncology. Bone & Joint 360 1:2, pages 27-28.
Crossref